Literature DB >> 30548075

Total Synthesis of Archazolid F.

Stephan Scheeff1, Dirk Menche1.   

Abstract

A partial bioinspired as well as the total synthesis of archazolid F, a highly potent V-ATPase inhibitory, antiproliferative polyketide macrolide, is described. Key features of the synthetic routes include a highly stereoselective aldol condensation of two elaborate fragments and macrocyclizations either by a Shiina macrolactonization or by a challenging RCM reaction of an octaene substrate. The syntheses unequivocally confirm the full architecture of this very scarce archazolid.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30548075     DOI: 10.1021/acs.orglett.8b03715

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  5 in total

1.  Synthesis of Tetramic Acid Fragments Derived from Vancoresmycin Showing Inhibitory Effects towards S. aureus.

Authors:  Lukas Martin Wingen; Marvin Rausch; Tanja Schneider; Dirk Menche
Journal:  ChemMedChem       Date:  2020-06-26       Impact factor: 3.466

2.  Design, Synthesis and Biological Evaluation of Highly Potent Simplified Archazolids.

Authors:  Solenne Rivière; Christin Vielmuth; Christiane Ennenbach; Aliaa Abdelrahman; Carina Lemke; Michael Gütschow; Christa E Müller; Dirk Menche
Journal:  ChemMedChem       Date:  2020-06-10       Impact factor: 3.466

3.  Suzuki coupling-based synthesis of VATPase inhibitor archazolid natural product derived fragments.

Authors:  Cooper T Vincent; Evan T Long; Holly C Jones; Jeffrey C Young; P Clint Spiegel; Gregory W O'Neil
Journal:  RSC Adv       Date:  2019-10-10       Impact factor: 4.036

Review 4.  Design and Synthesis of Simplified Polyketide Analogs: New Modalities beyond the Rule of 5.

Authors:  Dirk Menche
Journal:  ChemMedChem       Date:  2021-05-05       Impact factor: 3.466

5.  A Straightforward Synthesis of Polyketides via Ester Dienolate Matteson Homologation.

Authors:  Oliver Andler; Uli Kazmaier
Journal:  Chemistry       Date:  2020-12-15       Impact factor: 5.020

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.